Compare Huntington Ingalls Industries Inc (HII) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Ingalls Industries Inc vs Zimmer Biomet Holdings Inc — how do they compare? Huntington Ingalls Industries Inc trades at $265.67 (market cap $10.44B), while Zimmer Biomet Holdings Inc trades at $88.84 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and Huntington Ingalls Industries Inc pays the higher dividend (2.08%). Which is the better fit depends on your goals — on Pluang, investors hold Huntington Ingalls Industries Inc for 28 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| HII | ZBH | |
|---|---|---|
Market Cap | $10.44B | $16.95B |
Volume | 440,462 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $453.73 | $103.98 |
52-Week Low | $257.05 | $79.58 |
Typical Hold Time | 28 Days | 89 Days |
Enterprise Value | $13.37B | $24.02B |
Dividend Yield | 2.08% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HII trades at $260.67, down 1.17% with bearish technical signals but strong fundamentals. The company shows consistent earnings beats, with Q2 2026 EPS of $5.27 exceeding expectations by 39%. Recent contract wins including a $5.1 billion aircraft carrier overhaul and 10 unmanned vessel orders provide substantial revenue visibility. Valuation metrics appear reasonable with P/E of 15.78 and P/S of 0.79, while profitability metrics show ROE of 12.97% and net margin of 5.01%.
The investment case balances strong defense contracting fundamentals against technical weakness. Analyst consensus targets $363.67 (39% upside) with 40.7% buy ratings, though technical indicators show bearish momentum. Key risks include execution on large contracts and defense budget uncertainties, while catalysts include continued contract wins and autonomous technology expansion.
Zimmer Biomet (ZBH) trades at $88.70, up 0.24% on the day, with a bearish technical outlook but strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady, reaching $8.23B in 2025, while profitability metrics like a 69.87% gross margin and 9.48% net margin reflect operational efficiency. Recent corporate news includes a $0.24 quarterly dividend declaration and leadership promotions aimed at accelerating commercial transformation.
The investment outlook is mixed, with analyst consensus leaning hold (52.38%) but a price target of $103.11 suggesting 16% upside. Key opportunities include sustained earnings beats and strategic initiatives, while risks involve rising debt levels, competitive pressures, and technical bearish signals. The stock's current valuation at a P/E of 21.57 appears reasonable relative to growth prospects, but investors should weigh fundamental strength against near-term technical weakness and macroeconomic headwinds in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
